Misoprostol 600mcg Tablets

Misoprostol 600 mcg refers to a total dose of misoprostol, a synthetic prostaglandin E1 analogue that affects the stomach lining, cervix and uterus. Its clinical effects depend on the intended indication and prescribed regimen.

The 600 mcg amount is used in certain clinical protocols, including the medical management of incomplete abortion. It is a prescribed dose rather than a standard single-tablet strength; commonly available misoprostol tablets contain 200 mcg each.

Misoprostol is also used in other gastrointestinal, reproductive and obstetric settings, but the appropriate strength, route and regimen vary substantially. The actual product label and clinical indication must be confirmed before use or listing.

Product Information

Active Ingredient

Misoprostol

Dose Referenced

600 mcg (0.6 mg)

Common Tablet Strength

200 mcg (0.2 mg)

Dosage Form

Tablet

Drug Class

Prostaglandin E1 analogue

Reference Brand

Cytotec

Clinical Uses

Indication-specific gastrointestinal, reproductive and obstetric protocols

Pack Size

Verify the actual manufacturer's packaging

Prescription Status

Depends on country and intended use

Ordering and Availability

For misoprostol tablet pricing, pack sizes and availability, verify the actual tablet strength, manufacturer, packaging and intended product with the supplier.

Regulatory authorization, dispensing requirements and import eligibility differ by country and intended use. Confirm local requirements and obtain the medicine through an authorized pharmacy or eligible supplier.

Misoprostol may be used in several distinct clinical settings:

• Incomplete Abortion Management: A 600 mcg oral dose is included in some clinical guidelines for the medical management of incomplete abortion in specified circumstances.
• Postpartum Care: Misoprostol is used in selected protocols for prevention or treatment of postpartum haemorrhage, depending on the clinical situation and applicable guidance.
• Gastrointestinal Protection: Certain misoprostol products are indicated to reduce the risk of NSAID-associated gastric ulcers.
• Other Reproductive and Obstetric Care: Additional uses depend on the clinical protocol, product authorization and country-specific guidance.

These indications are not interchangeable. The prescribed regimen must match the specific medical need and authorized instructions.

Misoprostol dosing depends on the clinical indication, pregnancy status, administration route, patient history and relevant protocol.

A 600 mcg total dose should not be confused with the strength of a single tablet or used as a general regimen for every indication. Follow the prescribed instructions and official product information. Do not change the dose, route or timing without professional guidance.

For reproductive and obstetric uses, appropriate clinical assessment and access to follow-up care are important. Misoprostol is not a treatment for ectopic pregnancy.

Storage Instructions

Store misoprostol tablets according to the manufacturer's instructions. Protect the medicine from moisture and unsuitable storage conditions, and retain it in the original packaging where required.

Check the expiry date and packaging integrity before use. Keep medicines out of the reach of children.

Adverse effects depend on the indication and regimen. They can include:

• Diarrhoea
• Abdominal pain or cramping
• Nausea or vomiting
• Fever or chills
• Uterine contractions and vaginal bleeding in reproductive or obstetric use

Serious complications can include heavy bleeding, infection and, in certain obstetric circumstances, uterine rupture.

Seek urgent medical care for very heavy bleeding, severe or persistent abdominal pain, fainting, breathing difficulties or other signs of a serious complication.

Before use, the healthcare professional should review the indication, pregnancy status where relevant, medical history and current medicines.

Important precautions include:

• Pregnancy: Misoprostol can cause uterine contractions, pregnancy loss and other serious pregnancy-related complications.
• Gastrointestinal use: Follow the product-specific pregnancy warnings for ulcer-prevention treatment.
• Bleeding risk: Relevant bleeding disorders and medicines that increase bleeding risk should be reviewed.
• Previous uterine surgery: This may affect the risk profile in obstetric use.
• Clinical follow-up: Reproductive and obstetric treatment may require assessment to confirm the outcome and identify complications.

The appropriate contraindications and precautions depend on the intended use and product authorization. Consult the actual product leaflet.